Anavex Life Sciences Corp.

The BioFuture conference in New York featured panels that got into the nitty-gritty of drug development – from using artificial intelligence to improve the efficiency of drug development, to finding i

Nearly two years ago, Anavex Life Sciences Corp. posted iffy results with blarcamesine in a Phase III trial in adult Rett syndrome patients, prompting a share price fall. Now history has repeated, a

AriBio Co., Ltd. is set to become the first South Korean pharma firm to begin a global Phase III clinical development program for a novel drug for Alzheimer’s disease (AD), following an IND approval

Alzheimer’s disease treatment is finally set to be transformed following the recent US approval of Eisai and Biogen ’s Leqembi, and the upcoming approval decision for Eli Lilly ’s donanemab, but g